Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (beijing) Co., Ltd.

Clinical trials sponsored by Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (beijing) Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New shot tested to slow kidney disease in IgA nephropathy patients

Disease control Recruiting now

This study is testing an investigational injection called RG002C0106 for adults with IgA nephropathy, a kidney disease. It aims to see if the treatment safely reduces protein in the urine and helps protect kidney function over 24 weeks. The trial will involve about 30 participant…

Phase: PHASE2 • Sponsor: Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. • Aim: Disease control

Last updated Mar 12, 2026 13:52 UTC